Plain-English translation of NCT06249555 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn's Disease research guide →This study compares how quickly two types of newer medications work for Crohn's disease: vedolizumab and IL-23 antagonists. Researchers want to understand whether vedolizumab truly works more slowly than people think, or if it may actually work faster when given the full treatment schedule that doctors use in real practice. You would be tracked over time to report your own symptoms and experiences.
Patients and doctors care deeply about how fast a medication reduces symptoms and helps people feel better. This medication has a reputation for working slowly, but recent evidence suggests this belief might not be accurate—the original studies only measured results very early on. This trial will provide better information about the true speed of symptom improvement.
You would start one of the two medications as prescribed by your doctor—this study does not change your treatment plan. Over the course of the study, you would regularly answer questions about your symptoms and how you're feeling, using online surveys or questionnaires. Your doctor will follow you as usual, and researchers will track how quickly your symptoms improve and how well the medication is working for you.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
United States